GCK, glucokinase, 2645

N. diseases: 210; N. variants: 182
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE Maturity-onset diabetes of the young, type 2 (MODY2) is caused by mutations in the glucokinase gene (GCK). 18399931 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE This deleted region included GLI3 and GCK genes (where heterozygous mutations cause GCPS and MODY2, respectively), and many other contiguous genes. 22043488 2011
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease MGD Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. 9867845 1999
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus. 22060211 2012
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants. 8325892 1993
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Genetic and bioinformatics analysis of four novel GCK missense variants detected in Caucasian families with GCK-MODY phenotype. 24735133 2015
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2). 24578721 2014
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease MGD This collection of Gk mutants will be valuable for understanding GK gene function, for dissecting the function of the enzyme and as models of human MODY2 and PNDM. 15102714 2004
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT In this work, we describe the biochemical characterization of six missense glucokinase mutations associated with MODY2 from Spanish patients, namely, Y61S, V182L, C233R, E265K, A379V, and K420E. 18322640 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability. 25015100 2014
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR "MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of ""neonatal diabetes""?" 11079754 2000
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease MGD Novel phenotypes identified by plasma biochemical screening in the mouse. 12420138 2002
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT Mutations in the glucokinase gene of the fetus result in reduced birth weight. 9662401 1998
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease BEFREE Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. 18248649 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2). 18411240 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE We describe the clinical follow-up of two cases of MODY2 with two different mutations in GCK gene, one in exon 7, p.Glu265Lys (c.793 G> A), which has been previously described, and a novel one, in exon 2, p.Ser69Stop (c. 206C> G). 23295287 2012
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. 11508276 2001
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease BEFREE Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2). 31092478 2019
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. 27271189 2016
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients. 16965331 2006
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. 14517946 2003
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. 1303265 1992
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. 11508276 2001
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Six novel mutations in the GCK gene in MODY patients. 17204055 2007
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. 19790256 2009